Dixon Hubard Feinour & Brown Inc Zimmer Biomet Holdings, Inc. Transaction History

Dixon Hubard Feinour & Brown Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$102.23 - $133.85 $161,114 - $210,947	-1,576 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$108.42 - $129.58 $5,421 - $6,479	-50 Reduced 3.08%	1,576 $202,000
Q4 2021 Jan 10, 2022	BUY	$115.43 - $146.63 $187,689 - $238,420	1,626 New	1,626 $207,000
Q2 2021 Aug 23, 2021	SELL	$152.95 - $173.41 $298,711 - $338,669	-1,953 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$148.16 - $159.71 $14,667 - $15,811	99 Added 5.34%	1,953 $313,000
Q2 2020 Jul 31, 2020	SELL	$87.02 - $133.4 $16,881 - $25,879	-194 Reduced 9.47%	1,854 $249,000
Q3 2019 Nov 13, 2019	SELL	$113.33 - $138.46 $1,359 - $1,661	-12 Reduced 0.58%	2,048 $281,000
Q2 2019 Aug 14, 2019	BUY	$108.87 - $125.09 $1,306 - $1,501	12 Added 0.59%	2,060 $243,000
Q3 2017 Nov 08, 2017	BUY	$106.92 - $117.79 $218,972 - $241,233	2,048	2,048 $240,000

1,079

178M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.5B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.